Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis
Abstract Understanding the molecular basis of fibrosis, the lethal complication of COVID-19, is urgent. By the analysis of RNA-sequencing data of SARS-CoV-2-infected cells combined with data mining we identified genes involved in COVID-19 progression. To characterize their implication in the fibrosi...
Enregistré dans:
Auteurs principaux: | Elmira R. Vagapova, Timofey D. Lebedev, Vladimir S. Prassolov |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/af657faedb774b16b9c79f1776b9032d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Publisher Correction: Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis
par: Elmira R. Vagapova, et autres
Publié: (2021) -
Fibrotic microtissue array to predict anti-fibrosis drug efficacy
par: Mohammadnabi Asmani, et autres
Publié: (2018) -
Favorable Immune Microenvironment in Patients with EGFR and MAPK Co-Mutations
par: Yang W, et autres
Publié: (2020) -
A Cell-Based Platform for the Investigation of Immunoproteasome Subunit β5i Expression and Biology of β5i-Containing Proteasomes
par: Alexander Burov, et autres
Publié: (2021) -
A model of human lung fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis
par: Katy M. Roach, et autres
Publié: (2018)